B. Pharmacy- Lateral Entry

Fee Type	Amount
Programme Fees (per Semester)	₹90000
Examination Fees	₹3000

Course Curriculum

3RD SEMESTER SUBJECTS

Provides an introduction to machine learning concepts and their applications in drug discovery, pharmaceutical research, healthcare and data-driven decision-making.

Course Outcome:

CO1: Explain the basic concepts of artificial intelligence and machine learning, including types of learning and model development.
CO2: Apply regression models to analyze pharmaceutical data and interpret model outputs and performance metrics.
CO3: Analyze classification models for predicting categorical clinical outcomes using evaluation measures such as accuracy, sensitivity and ROC–AUC.
CO4: Interpret tree-based and ensemble learning models for decision-making in pharmaceutical and healthcare applications.
CO5: Utilize unsupervised learning techniques such as clustering to identify patterns in healthcare and pharmaceutical datasets.

Provides an understanding of environmental systems, pollution, conservation, sustainability and the impact of human activities on health and the environment.

Course Outcome:

CO1: Understand the basic concepts of environmental pollution, its types, causes and disaster management strategies.
CO2: Identify and categorize different types of pharmaceutical and biomedical waste generated in the healthcare and pharmaceutical sectors.
CO3: Describe the design and operation of Effluent Treatment Plants (ETPs), Sewage Treatment Plants (STPs) and water purification systems in pharma settings.
CO4: Analyze the environmental risks posed by pharmaceutical manufacturing, APIs and dosage forms.
CO5: Recognize the importance of sustainability and green pharmacy practices in the pharmaceutical industry.

Develops understanding of ethical principles, human values, responsible conduct and professional behavior for personal and societal well-being.

Course Outcome:

CO1: Explain the principles, content and process of Value Education and apply ethical values in day-to-day life.
CO2: Demonstrate self-awareness, right understanding, confidence and clarity about happiness and prosperity through self-exploration.
CO3: Distinguish between the needs and activities of the Self and the Body and establish harmony between them.
CO4: Apply values such as respect, affection, kindness, gratitude and love to maintain harmony in family and society.
CO5: Interpret the concept of harmony in nature and holistic existence, recognizing the four orders of nature and the comprehensive human goal.

Provides fundamental knowledge of drug actions, mechanisms, pharmacokinetics, pharmacodynamics, adverse effects and factors influencing drug response.

Course Outcome:

CO1: Relate the fundamental principles of pharmacodynamics and pharmacokinetics of drug actions on the human body.
CO2: Illustrate the processes involved in drug metabolism, toxicity and safety evaluation to relate their significance in the preclinical development of new drugs.
CO3: Apply the knowledge of pharmacological principles to efficacy, toxicity and safety evaluation of new drug candidates.
CO4: Assess the ethical and scientific principles underlying drug safety, efficacy and toxicity testing.
CO5: Appraise the recent trends in pharmacology.

Provides knowledge of heterocyclic compounds, stereochemical principles, reactions and their importance in pharmaceutical chemistry and drug activity.

Course Outcome:

CO1: Recall and outline methods for the preparation and chemical reactions of various organic compounds.
CO2: Explain the acidity and basicity of organic compounds and recognize the medicinal relevance of polynuclear hydrocarbons and heterocyclic compounds.
CO3: Illustrate the concepts of stereoisomerism with appropriate examples.
CO4: Classify, name and interpret the structures and chemistry of heterocyclic compounds.
CO5: Describe and analyze the synthesis, chemical behaviour and applications of heterocyclic and polynuclear hydrocarbon compounds.

Provides an understanding of the formulation, preparation, evaluation and quality requirements of conventional pharmaceutical dosage forms.

Course Outcome:

CO1: Describe pre-formulation principles and evaluate key physicochemical parameters critical to solid dosage-form development.
CO2: Apply formulation and manufacturing processes and perform quality control tests for tablets, including coated tablets and troubleshoot common formulation and processing defects.
CO3: Formulate and evaluate finely divided and filled solid dosage forms such as medicated powders, granules, hard capsules and soft gelatin capsules using appropriate materials, equipment and quality control procedures.
CO4: Design and evaluate modified-release solid dosage forms by selecting suitable polymers and mechanisms to achieve sustained and controlled drug release.
CO5: Analyze various microencapsulation methods, select suitable techniques for specific drug-delivery needs and evaluate microcapsules based on physicochemical and performance parameters.

Provides knowledge of engineering principles, unit operations and equipment used in the processing, manufacturing and handling of pharmaceutical products.

Course Outcome:

CO1: Explain the principles and pharmaceutical applications of unit operations such as size reduction, mixing, size separation and fluid flow.
CO2: Identify and describe the construction, working and utility of various pharmaceutical engineering equipment.
CO3: Compare and evaluate different thermal processes such as drying, evaporation, distillation and heat transfer based on operational efficiency.
CO4: Apply principles of safe and efficient material handling and understand the impact of corrosion and waste management in pharmaceutical industries.
CO5: Examine the relevance of contemporary technological trends such as PAT and automation for enhancing pharmaceutical manufacturing processes.

Provides an understanding of microorganisms, microbial growth, sterilization, contamination control and their applications in pharmaceutical sciences.

Course Outcome:

CO1: Explain the basic concepts of microbiology and the role of microorganisms in pharmaceuticals.
CO2: Identify and differentiate microorganisms using staining and biochemical techniques.
CO3: Evaluate microbial contamination sources and apply GMP-based strategies for contamination control.
CO4: Describe microbial spoilage mechanisms and select appropriate disinfectants, antiseptics, or preservatives.
CO5: Compare various sterilization methods and assess their effectiveness and validation parameters and perform microbial limit and sterility tests in compliance with pharmacopeial guidelines.

Develops practical understanding of drug effects, dose-response relationships, pharmacological experiments and basic evaluation of drug actions.

Course Outcome:

CO1: Identify and describe the pharmacological actions of drugs on different physiological systems and understand their therapeutic relevance.
CO2: Design basic pharmacological experiments and analyse the results to determine drug efficacy and safety.
CO3: Apply the knowledge of drug mechanisms and interactions to predict clinical outcomes.
CO4: Develop skills for documentation, data collection and report preparation of experimental pharmacological investigations.
CO5: Understand the importance of pharmacology in drug development, clinical research and its application in medical practice.

Develops practical skills in the synthesis, identification and characterization of heterocyclic compounds and understanding of stereochemical aspects.

Course Outcome:

CO1: Draw organic compound structures using chemical drawing tools.
CO2: Explain and apply techniques for purification and characterization of organic compounds.
CO3: Synthesize organic compounds through practical laboratory methods.
CO4: Analyze and separate binary organic mixtures using suitable experimental techniques.
CO5: Determine molecular properties of aromatic organic and heterocyclic compounds.

Develops practical skills in the formulation, preparation and evaluation of various conventional pharmaceutical dosage forms.

Course Outcome:

CO1: Conduct preformulation studies to evaluate physicochemical properties of drugs and excipients relevant to dosage form development.
CO2: Assess drug–excipient compatibility using appropriate experimental techniques during formulation development.
CO3: Formulate and evaluate solid dosage forms, including tablets and capsules, using suitable manufacturing methods.
CO4: Formulate and evaluate modified-release dosage forms and microcapsules using appropriate formulation and coating techniques.
CO5: Evaluate pharmaceutical packaging materials and understand their role in ensuring product stability and quality.

Provides knowledge of nutraceuticals, functional foods, bioactive components, health benefits and their role in disease prevention and wellness.

Course Outcome:

CO1 Classify and explain the functions of various nutraceuticals and functional foods.
CO2 Identify sources of important phytochemicals and dietary bioactives.
CO3 Perform basic laboratory techniques for nutraceutical product development.
CO4 Analyze labels and evaluate quality and efficacy of marketed supplements.
CO5 Understand regulatory frameworks (FSSAI, FDA, EFSA) and apply them in practice

Develops knowledge and practical skills for the analysis, quality assessment and detection of important components and contaminants in food.

Course Outcome:

CO1 Gain knowledge on nutritional and quality aspects of food products.
CO2 Understand troubleshoot common issues of instruments.
CO3 Execute and apply theoretical knowledge of food chemistry.
CO4 Understand the various analytical techniques for qualitative and quantitative analysis.
CO5 Understand the significance and application of food analysis in ensuring safety and quality.

Explores the scientific principles of yoga and its role in promoting physical health, mental well-being, stress management and a balanced lifestyle.

Course Outcome:

CO1 Perform basic yoga postures (asanas) and breathing exercises (pranayama). 2
CO2 Understand the physiological and psychological benefits of yoga.
CO3 Apply yoga techniques for stress relief, flexibility and mental clarity.
CO4 Recognize the therapeutic potential of yoga in managing chronic health conditions.
CO5 Integrate yoga into daily life for improved well-being and productivity.

4TH SEMESTER SUBJECTS

Provides knowledge of herbal drugs, their cultivation, processing, extraction, standardization, evaluation and formulation into safe and effective herbal products.

Course Outcome:

CO1: Demonstrate tissue culture applications for herbal drug production and edible vaccines.
CO2: Summarize the concept of standardized extracts and incorporate them in herbal formulations and cosmetics.
CO3: Apply analytical methods for quality control of herbal preparations.
CO4: Analyze herb–drug/food interactions and their clinical significance.
CO5: Interpret national regulatory provisions and global standards related to herbal drug development.

Provides an understanding of the chemical structure, synthesis, physicochemical properties, mechanisms and structure–activity relationships of medicinal compounds.

Course Outcome:

CO1: Relate the physicochemical properties of drug molecules to their biological activity and pharmacokinetic behavior.
CO2: Categorize drugs affecting the autonomic nervous system and predict their therapeutic outcomes.
CO3: Analyze and interpret the structure-activity relationships of selected drug classes (e.g., beta-blockers, local anesthetics, thiazide diuretics, NSAIDs) to optimize drug design.
CO4: Outline the synthetic routes of selected drugs, identifying key intermediates and reactions involved in their preparation.
CO5: Correlate the chemical structure of drugs with their therapeutic uses and potential adverse effects. Apply the knowledge of medicinal chemistry principles to understand and potentially contribute to the drug discovery and development process.

Provides knowledge of biotechnology principles and their applications in the production of medicines, vaccines, enzymes, recombinant products and other biopharmaceuticals.

Course Outcome:

CO1: Explain the role of biotechnology in pharmaceutical sciences, including monoclonal antibodies and enzyme immobilization.
CO2: Apply genetic engineering and recombinant DNA technology for the production of biopharmaceuticals such as insulin, interferons and vaccines.
CO3: Describe microbial biotransformation and analyze fermentation processes used in pharmaceutical industries.
CO4: Assess the role of bioinformatics and artificial intelligence in the Human Genome Project and personalized medicine.
CO5: Describe vaccine and sera development, including preparation, evaluation, standardization and regulatory requirements and critically evaluate challenges and emerging approaches in vaccine and sera development and commercialization.

Provides an understanding of public health, disease prevention, health promotion, national health programs and the role of pharmacists in community healthcare.

Course Outcome:

CO1: Describe the scope of social pharmacy and the pharmacist's role in the public health system.
CO2: Explain the influence of socio-cultural and behavioral factors on health, illness and medication adherence.
CO3: Discuss various national health programs and the pharmacist's contribution to their success.
CO4: Apply basic principles of epidemiology to understand disease distribution and control.
CO5: Develop health education materials and counsel patients on preventive healthcare measures and rational drug use.

Provides an understanding of the pharmacological actions, mechanisms, therapeutic uses and adverse effects of drugs acting on major body systems.

Course Outcome:

CO1: Explain the classification of neurotransmitters and describe neurohumoral transmission, including the organization, function and pharmacological modulation of the autonomic nervous system.
CO2: Classify and explain the mechanisms of action, pharmacological effects and therapeutic uses of drugs used in cardiovascular disorders such as heart failure, arrhythmias, hypertension, angina and lipid disorders.
CO3: Describe the pharmacology and therapeutic uses of drugs acting on blood and kidney, including anticoagulants, antiplatelet agents, hematinics and diuretics.
CO4: Explain the physiological roles of autacoids and analyze the pharmacology of drugs that modulate autacoid pathways, including antihistamines, antimigraine agents, NSAIDs and antirheumatic drugs.
CO5: Evaluate the mechanisms of action, therapeutic uses and adverse effects of drugs acting on the respiratory and immune systems.

Develops practical skills in the preparation, evaluation, standardization and quality control of herbal drugs and herbal formulations.

Course Outcome:

CO1: Perform seed germination and plant tissue culture of medicinal plants.
CO2: Prepare and standardize herbal extracts and enriched phytoconstituent fractions following official guidelines.
CO3: Evaluate excipients of natural origin and select suitable ingredients for herbal formulations.
CO4: Formulate and assess herbal cosmetics, dosage forms and novel delivery systems as per Pharmacopoeial standards.
CO5: Analyze and compare marketed herbal medicines and cosmetics for quality, compliance and performance

Develops practical skills in the synthesis, purification, identification and evaluation of medicinally important chemical compounds.

Course Outcome:

CO1: Demonstrate the ability to synthesize various drug molecules and intermediates using standard laboratory procedures.
CO2: Perform qualitative and quantitative assays of drugs with accuracy and precision.
CO3: Analyze and interpret drug monographs according to pharmacopeial standards.
CO4: Utilize appropriate instrumentation and techniques for drug preparation, assay and monograph analysis.
CO5: Document and report experimental procedures and results in a clear and concise manner

Provides hands-on experience with basic biotechnological techniques, microbial processes, enzyme technology and pharmaceutical biotechnology applications.

Course Outcome:

CO1: Explain the fundamental principles of biotechnology and apply genetic engineering and recombinant DNA technology concepts in pharmaceutical sciences.
CO2: Describe the production and applications of biopharmaceutical products such as protein therapeutics and monoclonal antibodies.
CO3: Explain the principles, delivery systems and ethical considerations associated with gene therapy.
CO4: Describe fermentation processes and microbial biotransformation involved in the large-scale production of pharmaceutical products such as vaccines, hormones and blood products.
CO5: Explain the principles of immunization, types of vaccines and sera and the regulatory and ethical considerations involved in the development of biopharmaceutical products.

Develops practical skills in health assessment, patient counselling, health education and community-based public health activities.

Course Outcome:

CO1 Perform basic health screening and first aid procedures using appropriate techniques
CO2 Develop and disseminate health promotion and disease prevention materials
CO3 Apply mental health screening tools and demonstrate patient assessment skills using role plays and relevant psychological scales.
CO4 Demonstrate vaccination techniques using appropriate models and standard protocols for immunization practices.
CO5 Interpret epidemiological data and apply to create preventive measures Evaluate healthcare interventions using pharmacoeconomic principles and recognize irrational drug use in real-world scenarios.

Develops practical understanding of drug actions through pharmacological experiments, dose-response studies and evaluation of therapeutic effects.

Course Outcome:

CO1 Describe the drug effects on blood pressure, heart rate and understand their relevance to cardiovascular pharmacotherapy through virtual simulations.
CO2 Evaluate the pharmacological management of asthma, analyse drug actions on the respiratory system and correlate them with clinical data.
CO3 Interpret experimental data, calculate and analyse PA2 values, plot standard curves and estimate drug effects using hypothetical data from computer simulations.
CO4 Present case studies and explore drug interactions and rational drug management in cardiovascular situations and asthma, applying pharmacological knowledge to patient care.
CO5 Demonstrate competence in various pharmacological measurements, such as intraocular pressure estimation, nitric oxide estimation in plasma and spirometry.

Provides practical exposure to professional pharmacy practice and enables students to apply their academic knowledge in real-world healthcare and pharmaceutical settings.

Course Outcome:

To provide students with practical, hands-on experience in pharmaceutical practice and professional environments, enabling them to apply theoretical knowledge, develop technical and professional skills and understand real-world pharmacy operations.

5TH SEMESTER SUBJECTS

Provides an understanding of the chemical basis of drugs, their molecular interactions, structure–activity relationships and design of biologically active medicinal compounds.

Course Outcome:

CO1: Classify and explain the chemistry, therapeutic use and structure–activity relationships of drugs acting on the central nervous system, including anesthetics, sedatives, antipsychotics and anticonvulsants.
CO2: Describe the chemical classification, mechanism of action and SAR of major anti-infective agents such as anti-tuberculars, antimalarials, antivirals, antifungals, anthelmintics and urinary tract anti-infectives.
CO3: Analyze the chemistry and SAR of antibiotics and sulfonamides and correlate structural features with antimicrobial activity and spectrum of action.
CO4: Explain the chemical basis, therapeutic significance and SAR of antineoplastic agents and endocrine drugs used in cancer and hormonal disorders.
CO5: Interpret the chemistry, pharmacological relevance and SAR of antidiabetic agents and narcotic analgesics, including opioid agonists and antagonists, for rational drug use and development.

Provides knowledge of the large-scale production, processing, standardization, quality control and industrial utilization of medicinal plants and natural products.

Course Outcome:

CO1: Describe the economic significance, trade potential, emerging therapeutic categories and institutional support for medicinal and aromatic plant–based industries at national and international levels.
CO2: Explain the principles of commercial production, standardization and quality control of herbal extracts, volatile oils, cosmeceuticals and traditional formulations in compliance with AYUSH, WHO-GMP and global regulatory norms.
CO3: Demonstrate analytical competence in evaluating herbal drugs and botanicals using modern spectroscopic and chromatographic techniques such as UV, IR, NMR, MS, HPTLC, HPLC, UPLC and GC.
CO4: Describe the process to isolate, characterize, identify and analyze important phytoconstituents used in pharmaceutical and nutraceutical industries.
CO5: Interpret and apply international regulatory guidelines, pharmacopoeial monographs and safety, efficacy and pharmacovigilance requirements for herbal and traditional medicinal products.

Develops understanding of innovation, entrepreneurship, intellectual property, business models and startup development within the pharmaceutical and healthcare sectors.

Course Outcome:

CO1: Explain the fundamental concepts of innovation, entrepreneurship and the structure and role of the startup ecosystem in economic and social development.
CO2: Identify and analyze problems, market gaps and opportunities using ideation tools, market research techniques and feasibility analysis.
CO3: Design and validate an innovative solution by developing a minimum viable product (MVP) using lean startup principles and customer feedback.
CO4: Develop an appropriate business model using the Business Model Canvas and evaluate legal, intellectual property, team and funding considerations for startups.
CO5: Demonstrate effective ecosystem engagement skills by participating in innovation events and presenting a concise startup pitch, incorporating future trends and scaling strategies.

Provides advanced knowledge of the formulation, manufacturing, evaluation and quality control of modern pharmaceutical dosage forms and drug delivery systems.

Course Outcome:

CO1: Explain the fundamental principles, classification, formulation requirements and quality aspects of monophasic and biphasic liquid dosage forms.
CO2: Formulate, manufacture and evaluate monophasic and biphasic liquid preparations, including solutions, syrups, elixirs, suspensions and emulsions, using appropriate excipients and processing techniques.
CO3: Apply physicochemical principles such as solubility enhancement, Stokes’ law, DLVO theory and emulsification theories to design stable liquid dosage forms and assess their stability and performance.
CO4: Design and evaluate pressurised and inhalation dosage forms, including aerosols, metered dose inhalers and dry powder inhalers, by selecting suitable formulation components, devices and quality control parameters.
CO5: Formulate, evaluate and justify the use of semisolid and advanced drug delivery systems—including ointments, creams, gels, suppositories, nanosuspensions, nano-emulsions, SMEDDS/SNEDDS, xerogels and emulgels—for enhanced drug delivery, stability and patient compliance.

Provides knowledge of quality management systems, GMP, validation, documentation, regulatory requirements and quality assurance practices in pharmaceutical manufacturing.

Course Outcome:

CO1: Explain the concepts of QA, QC, GMP, GLP and modern Quality Management Systems.
CO2: Apply TQM, QbD and ICH guidelines to ensure consistent pharmaceutical quality.
CO3: Understand requirements related to personnel, premises, equipment, materials, warehousing and pharmaceutical documentation.
CO4: Describe quality control testing of pharmaceutical products, raw materials and packaging materials and explain complaint handling and product recall procedures.
CO5: Explain calibration, qualification and analytical method validation as per applicable regulatory and ICH guidelines.

Provides an understanding of the pharmacological actions, mechanisms, therapeutic uses and adverse effects of drugs acting on major body systems.

Course Outcome:

CO1: Explain neurohumoral transmission in the CNS and the pharmacological actions and therapeutic uses of drugs acting on the central nervous system.
CO2: Explain the principles of chemotherapy and the mechanisms, therapeutic uses, adverse effects and resistance associated with major antimicrobial and chemotherapeutic agents.
CO3: Describe the pharmacology and therapeutic applications of drugs used in endocrine disorders, including thyroid, parathyroid, diabetes, corticosteroid, contraceptive and uterine therapies.
CO4: Explain the mechanisms, therapeutic uses and adverse effects of drugs acting on the gastrointestinal tract.
CO5: Describe the pharmacology of drugs used in psychiatric disorders and explain drug abuse, addiction, dependence, tolerance and principles of de-addiction.

Develops practical skills in the synthesis, identification, characterization and evaluation of biologically active medicinal compounds.

Course Outcome:

CO1: Successfully synthesize specified drug molecules and intermediates in the laboratory using appropriate synthetic techniques.
CO2: Demonstrate competence in using microwave irradiation or green chemistry approaches for efficient chemical synthesis.
CO3: Accurately perform drug assays to determine the concentration and purity of selected pharmaceutical substances.
CO4: Analyze physicochemical and ADME properties of drug candidates using suitable computational tools.
CO5: Conduct and interpret molecular docking studies to understand drug–target interactions and binding.

Develops practical skills in the extraction, isolation, standardization, evaluation and quality control of medicinal plants and natural products.

Course Outcome:

CO1: Apply chromatographic techniques for the isolation, separation and analysis of phytoconstituents.
CO2: Isolate and identify key phytoconstituents from medicinal plants using appropriate practical techniques.
CO3: Standardize Ayurvedic formulations and determine alcohol content using suitable analytical methods.
CO4: Prepare herbal drug monographs and assess traditional formulations according to relevant pharmacopoeial and traditional medicine standards.
CO5: Evaluate and analyze marketed and community-used traditional formulations through case studies and experiential learning.

Provides hands-on experience in the formulation, preparation, evaluation and quality testing of advanced pharmaceutical dosage forms.

Course Outcome:

CO1: Apply solubility-enhancement techniques and prepare monophasic liquid dosage forms such as syrups and related preparations.
CO2: Prepare and evaluate biphasic liquid dosage forms including emulsions, suspensions and dry powders for reconstitution.
CO3: Demonstrate the preparation and evaluation of semisolid dosage forms including creams and gels and study the effect of gelling agents on viscosity.
CO4: Prepare and evaluate specialized dosage forms including suppositories, pessaries and in-situ gels.
CO5: Prepare and evaluate emulgels and compare the effects of formulation parameters on the performance of biphasic and semisolid dosage forms.

Develops practical understanding of drug actions through pharmacological experiments, bioassays, dose-response studies and evaluation of therapeutic effects.

Course Outcome:

CO1: Evaluate selected CNS drug activities, including analgesic, antiepileptic, antidepressant, anxiolytic, antipsychotic and locomotor effects, using interactive computer simulations.
CO2: Evaluate learning and memory, antiulcer activity and selected bioassay-based drug responses using appropriate experimental or computer-simulation methods.
CO3: Estimate the potency or concentration of selected drugs using bioassay principles and matching, bracketing, or interpolation methods through interactive computer simulation.
CO4: Demonstrate understanding of cell culture techniques and evaluate antibacterial sensitivity testing using appropriate methods and case-based or simulated approaches.
CO5: Apply databases and computational tools to predict drug activity, ADME and toxicity, interpret electrophoretic protein/DNA analysis and construct pharmacological networks.

6TH SEMESTER SUBJECTS

Provides advanced knowledge of medicinal plants, natural products, phytoconstituents, their isolation, characterization, standardization and therapeutic applications.

Course Outcome:

CO1: Explain reverse pharmacology, traditional knowledge databases and bioprospecting strategies.
CO2: To analyze herbal drugs using metabolomics, spectral libraries and chemoinformatics tools.
CO3: Employ modern in-silico and AI techniques in lead identification and optimization from natural products.
CO4: Evaluate preclinical safety, pharmacokinetics and efficacy of bioactive leads.
CO5: Interpret global IP frameworks and develop strategies for patenting herbal products and protecting traditional knowledge.

Provides an understanding of drug absorption, distribution, metabolism, excretion, bioavailability, bioequivalence and pharmacokinetic principles governing drug disposition.

Course Outcome:

CO1: Interpret fundamental pharmacokinetic and pharmacodynamic principles and apply them to patient-centered clinical scenarios.
CO2: Evaluate the impact of physicochemical and biological variables on drug absorption, distribution and protein binding in clinical practice.
CO3: Differentiate among bioavailability classifications and develop bioequivalence study protocols that comply with international regulatory standards.
CO4: Solve pharmacokinetic problems using compartment models by employing numerical techniques
CO5: Design optimal dosing regimens, interpret non-linear pharmacokinetic behaviors and utilize simulation software for PK/PD analysis.

Provides knowledge of patents, trademarks, copyrights, intellectual property protection and their importance in pharmaceutical research, innovation and commercialization.

Course Outcome:

CO1: Understand the basic concepts and significance of intellectual property rights with respect to pharmaceutical industries.
CO2: Learn the types of intellectual property rights such as patents, copyrights, trademarks, trade secrets.
CO3: Understand the procedure for patent filing in India and abroad.
CO4: Understand the key provisions of the Indian Patent Act.
CO5: Evaluate and understand the strategies for IP management and product Commercialization.

Introduces artificial intelligence and machine learning applications in drug discovery, formulation development, pharmaceutical analysis, clinical research and healthcare.

Course Outcome:

CO1: Explain how pharmaceutical data from various domains can be structured for machine learning applications.
CO2: Interpret regression and classification models used in natural products and medicinal chemistry.
CO3: Analyze predictive modeling approaches in formulation, release and stability studies.
CO4: Evaluate AI applications in manufacturing process monitoring and quality prediction.
CO5: Assess analytical modeling and chemometric applications in pharmaceutical quality control.

Provides knowledge of analytical principles and instrumental techniques used for the identification, quantification, purity testing and quality control of pharmaceutical substances.

Course Outcome:

CO1: Explain the theoretical basis of electrochemical methods (potentiometry, conductometry, polarography, amperometry) and spectroscopic techniques (UV-Visible, IR, fluorometry, atomic absorption).
CO2: Explain the instruments involved in electroanalytical and spectroscopic methods.
CO3: Describe the principles, instrumentation and applications of various chromatographic and electrophoretic techniques.
CO4: Select suitable analytical techniques for specific pharmaceutical analysis requirements.
CO5: Analyze, interpret and report analytical data accurately and draw meaningful conclusions

Provides knowledge of pharmaceutical laws, regulations, professional ethics and legal requirements governing the manufacture, distribution, sale and practice of pharmacy.

Course Outcome:

CO1: Demonstrate understanding of major pharmaceutical legislations and explain their relevance in pharmaceutical product development and marketing.
CO2: Interpret and apply the provisions of various Indian pharmaceutical Acts and laws in real-world scenarios.
CO3: Identify regulatory bodies such as CDSCO, IPC and state regulatory authorities and explain their roles in drug approval, manufacturing and distribution.
CO4: Exhibit ethical awareness by applying the code of ethics in professional pharmaceutical practices.
CO5: Critically analyze regulatory frameworks and assess their impact on public health, industry operations and compliance requirements.

Introduces environmentally sustainable chemical principles and practices for reducing waste, toxicity, energy consumption and environmental impact in pharmaceutical processes.

Course Outcome:

CO1 Articulate the principles of green chemistry and provide relevant pharmaceutical examples for each.
CO2 Identify and propose suitable green solvents and catalysts,
CO3 Understand the advanced synthetic methods using Green synthesis using microwave, Ultrasonic for the production of active pharmaceutical ingredients (APIs).
CO4 Develop strategies for waste minimization and continuous flow reactor in pharmaceutical manufacturing in industries.
CO5 Articulate the principles of green chemistry and provide relevant pharmaceutical examples for each.

Provides knowledge of monitoring, detection, assessment and prevention of adverse events associated with medical devices, blood and blood components.

Course Outcome:

CO1 Explain the principles, scope and significance of materiovigilance and hemovigilance in ensuring patient and public health safety.
CO2 Describe the structure and functioning of the Materiovigilance Programme of India (MvPI) and the procedures for reporting medical device-related adverse events.
CO3 Outline the framework of the Hemovigilance Programme of India (HvPI) and classify different types of transfusion-related adverse reactions.
CO4 Compare national and international vigilance systems and apply basic methods of risk assessment, signal detection and root cause analysis.
CO5 Demonstrate appropriate documentation and reporting practices and recognize the role of healthcare professionals in promoting vigilance and patient safety.

Develops skills in scientific communication, research writing, manuscript preparation, referencing, publication ethics and effective presentation of scientific information.

Course Outcome:

CO1 Understand the principles of scientific writing
CO2 Develop clear and concise scientific writing skills
CO3 Use effective scientific citation techniques
CO4 Understand and apply the ethical principles of scientific writing
CO5 Develop the ability to critically evaluate scientific literature

Provides knowledge of pharmaceutical business operations, inventory management, purchasing, sales, accounting, marketing and efficient management of drug stores.

Course Outcome:

CO1 Describe different business models and their relevance to pharmaceutical trade. 2
CO2 Manage drug store operations, including procurement, storage and customer service.
CO3 Maintain basic accounting records and interpret financial statements.
CO4 Implement inventory control techniques and pricing policies.
CO5 Apply marketing principles and legal guidelines for establishing a retail pharmacy.

Provides knowledge and practical guidance on medicinal plant cultivation, entrepreneurship, value addition and career opportunities in the herbal and pharmaceutical sector.

Course Outcome:

CO1 Explain the importance and historical development of medicinal plants in traditional and modern healthcare systems.
CO2 Describe the structure and functioning of the medicinal plant industry and its economic significance.
CO3 Identify major medicinal plants of India and explain their uses and sources.
CO4 Apply principles of sustainable and organic cultivation practices for medicinal plants.
CO5 Analyze entrepreneurship opportunities and value chain development in the medicinal plant sector.

Provides knowledge of APIs and pharmaceutical excipients, including their properties, selection, functionality, quality requirements and role in formulation development.

Course Outcome:

CO1 To explain the classification, properties and functional roles of APIs and excipients.
CO2 To apply analytical and preformulation methodologies for compatibility and stability evaluation.
CO3 To understand manufacturing, scale-up and quality control procedures used in industry.
CO4 To evaluate regulatory documentation and compliance requirements for API and excipient approval.
CO5 To develop awareness of current industrial practices and innovation trends

Develops practical skills in evaluating drug absorption, bioavailability, pharmacokinetic parameters and drug disposition using experimental and computational approaches.

Course Outcome:

CO1: Explain the fundamental concepts, types and applications of NDDS in modern therapeutics and precision medicine.
CO2: Design and prepare advanced drug delivery systems such as orodispersible tablets, bilayer tablets, osmotic systems, microspheres, microcapsules, buccal/sublingual dosage forms, transdermal patches, gastroretentive systems and lipid-based carriers.
CO3: Select appropriate excipients and techniques for the development of NDDS considering drug properties, patient needs and target site requirements.
CO4: Perform evaluation and quality control tests for novel formulations to ensure efficacy, stability and patient compliance.
CO5: Integrate NDDS strategies into precision medicine frameworks to optimize dosing, therapeutic targeting and individualized treatment plans.

Develops practical skills in pharmaceutical identification, assay, purity testing and quantitative analysis using classical and instrumental analytical techniques.

Course Outcome:

CO1: Perform accurate titrations (potentiometric and conductometric) to determine the endpoint of acid-base reactions.
CO2: Determine absorption maxima, perform assays and analyze multi-component formulations using spectrophotometric and colorimetric techniques.
CO3: Identify functional groups in compounds using FTIR spectroscopy and conduct quantitative analysis using fluorimetry and flame photometry.
CO4: Separate and analyze mixtures of compounds using paper chromatography, thin-layer chromatography (TLC), gas-liquid chromatography (GLC), high-performance liquid chromatography (HPLC) and high-performance thin-layer chromatography (HPTLC).
CO5: Interpret spectral and chromatographic data to identify compounds and quantify analytes.

Provides practical exposure to computational techniques used for molecular modeling, virtual screening, molecular docking and rational drug design.

Course Outcome:

CO1 Retrieve and prepare biological targets from protein databases and analyze active sites using molecular modelling tools.
CO2 Design and optimize ligand structures and generate energetically stable conformers for computational drug design studies.
CO3 Perform molecular docking and analyze drug–target interactions to evaluate ligand binding affinity and stability.
CO4 Apply pharmacophore modelling and QSAR methods for virtual screening and prediction of biological activity.
CO5 Evaluate drug candidates using ADMET prediction tools and molecular dynamics simulations to assess drug-likeness and complex stability

Develops practical skills in developing, optimizing and validating analytical methods for reliable pharmaceutical quality assessment.

Course Outcome:

CO1 Develop and optimize analytical methods using UV–Visible spectrophotometry, HPLC, GC and titrimetric techniques for pharmaceutical substances.
CO2 Construct calibration curves and perform quantitative estimation of APIs and formulations with appropriate analytical validation.
CO3 Select and optimize chromatographic conditions including column type, mobile phase composition, flow rate, temperature and detection wavelength.
CO4 Apply analytical method validation parameters such as LOD, LOQ and robustness to ensure reliability and regulatory compliance.
CO5 Conduct stability-indicating and impurity-related studies, including forced degradation, dissolution testing and residual solvent analysis.

Provides practical understanding of the design, conduct, evaluation and ethical considerations of preclinical studies for assessing the safety and efficacy of new drugs.

Course Outcome:

CO1 Explain the role and significance of preclinical studies in drug discovery and development.
CO2 Demonstrate appropriate laboratory animal handling practices in accordance with ethical and regulatory guidelines.
CO3 Analyze pharmacokinetic parameters obtained from preclinical animal studies.
CO4 Design and interpret basic toxicological studies to evaluate drug safety.
CO5 Apply preclinical data in assessing drug candidates for progression to clinical trials.

Develops professional competencies including teamwork, leadership, presentation, problem-solving, workplace communication and employability skills.

Course Outcome:

CO1 Demonstrate professional communication skills in interviews, emails, presentations and workplace meetings.
CO2 Prepare and present an industry-standard résumé and professional online profile.
CO3 Exhibit confidence and clarity during group discussions, presentations and interviews.
CO4 Apply time management, decision-making and conflict resolution strategies in professional situations.
CO5 Maintain workplace ethics, etiquette and a professional demeanor in both physical and digital environments

Provides practical understanding of Quality by Design and Process Analytical Technology approaches for systematic formulation development, process optimization and pharmaceutical quality assurance.

Course Outcome:

CO1 Describe the role of PAT and QbD in ensuring consistent product quality throughout a formulation process.
CO2 Identify and justify key CQAs, CPPs and potential failure modes for a solid-dosage product.
CO3 Collect and interpret real-time data from an NIR or FBRM sensor and decide when a blend or granulation meets targets.
CO4 Design and analyse a small factorial experiment that optimises at least one CQA within a defined design space.
CO5 Prepare a brief risk-control plan showing ranked RPN values and proposed PAT-based monitoring to enable RTRT

Provides experiential learning through supervised professional exposure, enabling students to apply pharmaceutical knowledge and develop workplace competencies in real-world settings.

Course Outcome:

7TH SEMESTER SUBJECTS

Provides knowledge of statistical methods, research design, data analysis, interpretation and scientific approaches used in pharmaceutical and healthcare research.

Course Outcome:

CO1: Explain the basic concepts of biostatistics including variables, sampling methods, descriptive statistics and graphical representation of biomedical data.
CO2: Apply probability concepts and probability distributions (binomial, Poisson, normal, t, F and chi-square distributions) in pharmaceutical and healthcare data analysis.
CO3: Analyze relationships between variables using correlation and regression techniques and interpret their applications in pharmaceutical research.
CO4: Perform inferential statistical analysis including estimation, confidence intervals, hypothesis testing, ANOVA and non-parametric tests for research decision-making.
CO5: Design and evaluate research studies by selecting appropriate research designs, sampling techniques and statistical methods and demonstrate competence in scientific reporting and ethical research practices.

Provides knowledge of cosmetic and cosmeceutical ingredients, formulation, preparation, evaluation, safety and applications for skin, hair and personal care.

Course Outcome:

CO1: Classify cosmetics and cosmeceuticals based on application and dosage forms and outline the role of formulation excipients.
CO2: Describe the formulation, preparation, packaging and evaluation of cosmetics for skin, hair and oral care, including herbal products.
CO3: Demonstrate knowledge of formulation and quality assessment of commonly used cosmetic products such as shampoos, soaps, lotions and decorative cosmetics.
CO4: Identify the functional roles of cosmetic ingredients in managing skin, hair and oral conditions.
CO5: Explain the roles of regulatory bodies and labeling standards and discuss the integration of AI in personalized cosmetic formulation and virtual applications.

Introduces applications of artificial intelligence in clinical practice, including clinical decision support, diagnosis, patient monitoring, drug development and healthcare data analysis.

Course Outcome:

CO1: Explain the applications of AI & ML in pharmacokinetics, pharmacodynamics and clinical decision-making.
CO2: Apply regression and classification models to analyze clinical, pharmacokinetic and pharmacovigilance datasets.
CO3: Interpret predictive model outputs for adverse drug reactions, therapeutic response and clinical risk assessment.
CO4: Evaluate the performance of machine learning models using healthcare metrics such as accuracy, sensitivity, specificity, precision, recall and RMSE.
CO5: Analyze real-world healthcare datasets and assess the ethical and practical implications of AI-based clinical decision support systems.

Provides advanced knowledge of modern instrumental techniques used for the identification, separation, quantification, characterization and quality assessment of pharmaceutical substances.

Course Outcome:

CO1: Apply the principle of Mass and NMR spectra in the structural elucidation of organic compounds.
CO2: Determine the physical nature of the drugs and excipients using thermal studies, X ray crystallographic techniques and microscopy based analytical techniques.
CO3: Apply the basic knowledge on radio immune assays in carrying out the immunological studies.
CO4: Understand the theoretical and practical’s aspects of the latest hyphenated Chromatographic techniques used for analysis of drugs.
CO5: Apply green analytical chemistry techniques for environmental sustainability

Provides knowledge of the detection, assessment, monitoring, prevention and reporting of adverse drug reactions to ensure safe and rational use of medicines.

Course Outcome:

CO1: Explain the core concepts, objectives and significance of pharmacovigilance and immunovigilance.
CO2: Interpret and analyze national and global regulatory frameworks related to drug and vaccine safety.
CO3: Identify, document and report ADRs and AEFIs using appropriate pharmacovigilance systems.
CO4: Evaluate pharmacovigilance data to detect trends, safety signals and risk factors associated with medicinal products.
CO5: Propose and implement risk management strategies aimed at improving patient safety and public health outcomes

Provides knowledge of patient-centered pharmacy services, prescription evaluation, medication management, patient counselling and the clinical role of pharmacists.

Course Outcome:

CO1: Describe the evolution, scope and settings of pharmacy practice, including roles of pharmacists in various levels of healthcare.
CO2: Explain the organization and functions of hospital and community pharmacies, including drug distribution systems and regulatory standards.
CO3: Demonstrate clinical pharmacy services such as drug therapy monitoring, drug information and handling medication-related problems.
CO4: Apply patient-oriented services like medication adherence strategies, patient counseling and communication techniques.
CO5: Interpret and apply prescribing guidelines, essential drug concepts and principles of rational drug use for optimal pharmacotherapy.

Provides knowledge of pharmaceutical regulatory requirements, drug approval processes, documentation, compliance and regulatory frameworks governing medicines and healthcare products.

Course Outcome:

CO1: Describe the fundamental concepts and organizational structures of regulatory affairs and global regulatory authorities governing pharmaceutical products.
CO2: Describe the drug discovery and development process, including preclinical, clinical and regulatory documentation requirements.
CO3: Summarize the regulatory framework, approval procedures and legal requirements for pharmaceuticals in India.
CO4: Compare regulatory approval processes and submission formats across major international markets.
CO5: Understand clinical trial requirements, ethics committee roles, informed consent, GCP guidelines and pharmacovigilance requirements.

Provides knowledge of current GMP principles, quality systems, documentation, validation and regulatory requirements for ensuring consistent pharmaceutical product quality.

Course Outcome:

CO1: Understand the structure of SOPs, its writing and approval system, Importance of training, development, training needs identification and evaluation.
CO2 Understand the major FDA guidelines (regulated and semi regulated markets) and its understanding.
CO3 Impart knowledge on manufacturing assurance, analytical assurance, engineering assurance etc and handling systems for non-conformances.
CO4 Procedures used to investigate market complaints and its closure.
CO5 Impart knowledge on preparing for the regulatory audits, reports handling and drafting of compliance report, with certain understanding of Do’s and Don’ts during the audits.

Introduces automation technologies, computerized systems, process control, robotics and digital solutions used to improve efficiency, quality and safety in pharmaceutical manufacturing.

Course Outcome:

CO1 Explain the principles and advantages of automation in pharmaceutical processes.
CO2 Identify and describe various automated systems used in production and quality control.
CO3 Apply knowledge of instrumentation and control systems like SCADA and PLC in pharma environments.
CO4 Analyze the role of automation in enhancing data integrity, regulatory compliance and productivity.
CO5 Evaluate new trends like Industry 4.0, IoT and AI applications in pharmaceutical automation.

Provides knowledge of contemporary cellular biology techniques used to study cell structure, function, signaling, genetics and cellular responses in biomedical research.

Course Outcome:

CO1 Explain key principles of CRISPR editing, flow cytometry/FACS, live-cell imaging, single-cell RNA-seq and advanced fluorescence microscopy.
CO2 Design and carry out one basic protocol for each technique (e.g., gRNA design, fourcolour FACS run, 12-h time-lapse capture, scRNA-seq data import, confocal Z-stack acquisition).
CO3 Interpret the resulting data by creating clear plots, images, or cluster maps and extracting at least one biological conclusion from each.
CO4 Choose the right technique for a given cellular-biology question and justify the choice with brief technical and practical reasoning.
CO5 Apply essential safety, ethical and data-quality guidelines while performing and reporting every experiment

Provides an understanding of medical devices, their classification, design, development, evaluation, quality standards, regulatory requirements and clinical applications.

Course Outcome:

CO1 Analyze Market Trends and Regulatory Policies: Assess the evolution of the medical device industry and the impact of regulatory frameworks on market dynamics across regions.
CO2 Design Safe, Effective and Compliant Medical Devices: Apply design principles, emerging technologies (sensors, electronics, software) and appropriate biomaterials to develop medical devices that ensure safety, efficacy, biocompatibility and functionality.
CO3 Implement Quality and Risk Management Systems: Apply ISO 13485 standards, risk management processes and ethical principles to ensure quality, safety and responsible device development.
CO4 Navigate Global Regulatory Pathways: Understand and apply regulatory approval processes for medical devices in India, the US, the EU and other regions.
CO5 Develop Post-Market Surveillance Strategies: Design and implement strategies to monitor performance, safety and compliance of medical devices after market launch

Explores sustainable approaches for converting food waste and bioactive by-products into valuable pharmaceutical, nutraceutical and medicinal products.

Course Outcome:

CO1 Identify types, sources, impacts and regulations related to food waste.
CO2 Apply principles and sustainable technologies for effective food waste management.
CO3 Explain the conversion of food waste into biofuels, biopolymers and other valueadded products.
CO4 Assess bioactive compounds derived from food waste and their industrial and health applications.
CO5 Understand the role of AI, IoT and blockchain in smart food waste management systems

Provides knowledge of biologics, biosimilars, vaccines and therapeutic macromolecules, including their development, production, characterization and regulatory considerations.

Course Outcome:

CO1 Describe the structure and therapeutic roles of biological macromolecules, biosimilars and vaccines.
CO2 Apply analytical methodologies for characterization and bioequivalence assessment.
CO3 Understand upstream and downstream processing and formulation protocols.
CO4 Understand quality control, stability testing and immunogenicity assessment methods used for ensuring the safety and efficacy of biologics and vaccines.
CO5 Assess regulatory compliance requirements across the product lifecycle.

Study of personalized healthcare approaches that use an individual’s genetic, environmental and lifestyle factors to optimize disease prevention, diagnosis and treatment.

Course Outcome:

CO1 Define precision medicine and explain its evolution from conventional therapy to personalized healthcare approaches, highlighting the role of pharmacists and interdisciplinary collaboration.
CO2 Describe basic human genetics and pharmacogenomic principles and interpret genotype–phenotype relationships affecting drug response and adverse drug reactions.
CO3 Analyze the role of genetic polymorphisms (e.g., CYP450 enzymes) and utilize pharmacogenomic resources and databases such as PharmGKB and CPIC in clinical decision-making.
CO4 Classify biomarkers and evaluate their role in targeted therapies and companion diagnostics, with reference to real-world clinical case studies as targeted nanocarriers, antibody–drug conjugates and smart delivery systems
CO5 Define precision medicine and explain its evolution from conventional therapy to personalized healthcare approaches, highlighting the role of pharmacists and interdisciplinary collaboration.

Develops practical skills in the application of modern instrumental techniques for pharmaceutical analysis, identification, quantification and quality evaluation.

Course Outcome:

CO1 Analyze and interpret proton NMR, carbon NMR, mass spectra, X-Ray diffraction patterns and DSC thermograms to characterize pharmaceutical compounds.
CO2 Perform quantitative analysis of official pharmaceutical compounds using UHPLC.
CO3 Design and assess the suitability of green analytical solvents for pharmaceutical applications, promoting sustainability.
CO4 Construct a comprehensive protocol for bioavailability and bioequivalence studies adhering to USFDA regulatory standards.
CO5 Employ appropriate extraction techniques (SPE, PPE, LLE) for the accurate quantification of pharmaceuticals in biological fluids and matrices and explain and execute the MTT assay for evaluating cell viability in a laboratory setting.

Provides hands-on research experience involving literature review, experimental design, data collection and analysis, scientific interpretation and research reporting in pharmaceutical sciences.

Course Outcome:

To develop students’ research skills by enabling them to identify a relevant pharmaceutical problem, design and conduct a systematic research study, analyze and interpret findings and present the results in a scientific manner.

8TH SEMESTER SUBJECTS

Provides an understanding of ethical, regulatory and practical considerations in applying artificial intelligence to pharmaceutical research, drug development and healthcare.

Course Outcome:

CO1: Explain the lifecycle of AI systems in pharmaceutical settings.
CO2: Evaluate model performance, bias and validation requirements.
CO3: Discuss regulatory and governance frameworks applicable to AI in pharmacy.
CO4: Analyze AI applications in automation and public health analytics.
CO5: Evaluate ethical considerations in AI applications for pharmaceutical sciences and healthcare.

Provides knowledge of the rational use of medicines for the prevention and treatment of diseases through evidence-based pharmacotherapy and patient-centered care.

Course Outcome:

CO1: Understand the subjective and objective parameters and risk factors for common disease conditions.
CO2: Describe the general therapeutic approach in the management of selected diseases.
CO3: Identify the patient-specific parameters relevant in initiating drug therapy.
CO4: Discuss the rationale for drug therapy of selected diseases.
CO5: Understand the methods of non-pharmacological management.

Provides knowledge of pharmaceutical manufacturing processes, facility planning, equipment selection, layout design and regulatory requirements for efficient production.

Course Outcome:

CO1: Interpret regulatory guidelines (ICH, WHO, Schedule M, SUPAC) relevant to pharmaceutical product development, stability studies and manufacturing processes.
CO2: Explain pilot plant operations and scale-up strategies for the development of solid, liquid and semi-solid pharmaceutical dosage forms.
CO3: Describe the processes, documentation and quality management principles involved in technology transfer from R&D to manufacturing.
CO4: Design and evaluate facility layouts and utility systems for sterile and non-sterile pharmaceutical manufacturing in accordance with cGMP and global cleanroom standards.
CO5: Assess modern pharmaceutical facility design approaches, including modular cleanrooms, automation and validation systems, to ensure efficient and compliant manufacturing operation.

Provides knowledge of management principles, leadership, human resources, financial management, operations and strategic decision-making in the pharmaceutical sector.

Course Outcome:

CO1: Demonstrate a comprehensive understanding of the pharmaceutical industry, including drug development, regulatory processes, manufacturing and distribution.
CO2: Understand the role of pharmaceutical companies in healthcare and their impact on society at large.
CO3: Apply strategic management principles to solve complex issues in the pharmaceutical industry, including market entry, competitive advantage and business growth strategies.
CO4: Formulate and evaluate strategic business plans for pharmaceutical companies, considering global and local market dynamics.
CO5: Develop and implement pharmaceutical marketing strategies that align with both business goals and regulatory guidelines. Apply advanced sales and marketing techniques tailored to the pharmaceutical industry, focusing on product positioning, customer segmentation and digital marketing.

Provides advanced knowledge of sterile product formulation and manufacturing along with innovative drug delivery systems designed to improve drug efficacy, safety and patient compliance.

Course Outcome:

CO1: Classify and explain the different types of NDDS and describe their need in overcoming limitations of conventional drug delivery.
CO2: Identify appropriate pharmaceutical ingredients for designing site-specific or controlled-release delivery systems.
CO3: Design oral, mucosal, parenteral and transdermal NDDS and evaluate their mechanisms and formulation parameters.
CO4: Apply QbD principles and preclinical evaluation tools to assess NDDS quality and safety.
CO5: Demonstrate an understanding of the scope, principles and challenges of precision medicine in modern pharmacotherapy.

Provides knowledge of packaging materials, systems, design, evaluation, stability and regulatory requirements for protecting pharmaceutical products.

Course Outcome:

CO1 Understand the purpose and function of packaging in pharmaceuticals, including primary, secondary and tertiary packaging.
CO2 Identify and evaluate the materials used in pharmaceutical packaging and their interactions with dosage forms.
CO3 Design and select appropriate packaging materials during product development.
CO4 Apply quality control and regulatory principles to packaging processes.
CO5 Recognize advancements in packaging technology, including child-resistant packaging, tamper-evident packaging and automation.

Provides knowledge of procurement, inventory, logistics, distribution, forecasting and supply chain optimization in the pharmaceutical industry.

Course Outcome:

CO1 Analyze and design efficient supply chains.
CO2 Implement effective procurement and supplier management strategies.
CO3 Optimize logistics and distribution networks
CO4 Leverage technology for supply chain innovation.
CO5 Develop sustainable and resilient supply chain practices and importance of cold chain management.

Provides knowledge of workplace safety, hazard control, environmental protection and safe management and disposal of pharmaceutical and industrial waste.

Course Outcome:

CO1 Identify hazards in industrial settings and apply preventive safety measures.
CO2 Conduct risk assessments and implement control strategies for workplace safety.
CO3 Classify and manage different types of industrial waste generated in pharmaceutical sectors.
CO4 Apply suitable treatment and disposal methods for hazardous and non-hazardous waste.
CO5 Interpret and follow safety and environmental regulations applicable to industrial practices.

Explores traditional Indian systems of healing, medicinal practices, herbal remedies and their scientific and contemporary healthcare relevance.

Course Outcome:

CO1 Understand the foundational concepts and history of traditional healing systems in India.
CO2 Explore the various regional healing practices and their sociocultural relevance.
CO3 Analyse the integration of traditional and modern healthcare systems.
CO4 Develop a critical appreciation of indigenous knowledge systems in health and healing.
CO5 Encourage scientific validation and policy-level integration of traditional health knowledge

Introduces applications of augmented and virtual reality, digital technologies, automation and smart manufacturing in the transformation of pharmaceutical education and industry.

Course Outcome:

CO1 Explain the core principles of Pharma 4.0 and distinguish immersive technologies (AR, VR, MR, XR) and their components relevant to pharmaceutical applications.
CO2 Demonstrate hands-on proficiency in using AR/VR hardware and software tools to create basic immersive pharmaceutical experiences.
CO3 Apply AR/VR technologies in drug discovery, molecular modeling and collaborative virtual research environments.
CO4 Design AR/VR training simulations and SOP overlays for pharmaceutical manufacturing, GMP practices and quality control.
CO5 Develop and present immersive pharma solutions that meet compliance standards, validation protocols and Pharma 4.0 integration needs.

Provides knowledge of herbal cosmetic ingredients, formulation, manufacturing, quality evaluation, safety and industrial applications of plant-based personal care products.

Course Outcome:

CO1 Know about the materials, capital and infrastructural requirements along with understanding the fundamentals of Entrepreneurship
CO2 Understand the specifications and importance of adhering to Good Manufacturing Practices (GMP)
CO3 Know the guidelines and testing requirements for ensuring quality and safety of herbal cosmetics.
CO4 Acquire knowledge about legal and regulatory requirements for manufacturing and import of herbal cosmetics. Also the labelling requirements and regulations for advertising. With emphasis on the Drugs and Cosmetics Act (1940) and rules (1945) of India. Along with the regulatory approval process and their registration in Indian and international markets.
CO5 Know about the materials, capital and infrastructural requirements along with understanding the fundamentals of Entrepreneurship

Develops practical skills in pharmaceutical marketing, product promotion, market analysis, communication, sales strategies and professional customer engagement.

Course Outcome:

CO1 Understand the dynamics of the pharmaceutical market and the various factors that influence sales, including consumer behavior, competition and regulatory environment.
CO2 Design and implement effective marketing strategies for pharmaceutical products, tailored to specific market needs and target audiences.
CO3 Demonstrate knowledge of the ethical and legal considerations in pharmaceutical marketing and how to ensure compliance with industry standards and regulations.
CO4 Implement digital marketing strategies, such as social media campaigns, search engine optimization (SEO) and online advertisements, to promote pharmaceutical products.
CO5 Develop and demonstrate strong interpersonal and communication skills, necessary for building relationships with healthcare professionals, patients and other stakeholders in the pharmaceutical industry

Develops practical skills in the preparation and evaluation of sterile dosage forms and the application of novel drug delivery technologies.

Course Outcome:

CO1 Explain the fundamental concepts, types and applications of NDDS in modern therapeutics and precision medicine.
CO2 Design and prepare advanced drug delivery systems.
CO3 Select appropriate excipients and techniques for the development of NDDS.
CO4 Perform evaluation and quality control tests for novel formulations to ensure efficacy, stability and patient compliance.
CO5 Integrate NDDS strategies into precision medicine frameworks to optimize dosing, therapeutic targeting and individualized treatment plans

Provides practical understanding of cleaning validation procedures used to demonstrate the effective removal of product residues, contaminants and microorganisms from pharmaceutical equipment.

Course Outcome:

CO1 Explain the purpose and importance of cleaning validation.
CO2 Develop cleaning validation protocols and methods for pharmaceutical equipment.
CO3 Understand and apply residue detection techniques such as HPLC and TOC.
CO4 Evaluate cleaning effectiveness and compliance with regulatory standards.
CO5 Prepare detailed cleaning validation reports and perform revalidation when necessary

Develops practical skills in aseptic handling, contamination control, sterile practices and safe manipulation of materials in controlled pharmaceutical environments.

Course Outcome:

CO1 Explain the key concepts of asepsis, clean-room classifications and contamination control.
CO2 Demonstrate full sterile gown-up and hand-wash without contamination spots.
CO3 Set up and operate a laminar-airflow workstation and perform aseptic liquid transfers with no spills.
CO4 Complete a mini media-fill that meets sterility acceptance criteria (> 95 % clear vials).
CO5 Record and interpret environmental and personnel monitoring data, flagging any values above action limits.

Develops practical skills in the identification, characterization, quantification and control of impurities in pharmaceutical substances and products.

Course Outcome:

CO1 Explain the principles and significance of impurity profiling in pharmaceutical analysis.
CO2 Identify methods for detection and quantification of organic, inorganic and residual impurities.
CO3 Follow ICH and pharmacopeial guidelines for impurity limits and documentation.
CO4 Perform impurity analysis using HPLC, GC, UV and IR techniques.
CO5 Evaluate and interpret impurity data for regulatory submissions and quality assurance

Provides advanced research experience involving problem identification, literature review, experimental investigation, data analysis, interpretation and scientific reporting in pharmaceutical sciences.

Course Outcome:

Admissions Open 2026-27

Know About Us

Entrepreneurship

Development & Skill Enhancement

Experience @ Campus

Campus

about university

Academic Info

Schools

Programs

Admission

Student Life

University Fest

Student Welfare

Placements

IQAC

Research and Development Cell

International

Important-Links

Bachelor of Pharmacy (Lateral Entry)

Programme Details

About the Programme

Industry Immersion

Eligibility Criteria

Register Now

Why CT University is the Right Choice for Your Future

Industry-oriented learning

Modern campus facilities

Academic excellence & mentorship

Global opportunities & placements

Fee Structure & Scholarships

Program Fee Details

Course Curriculum

3RD SEMESTER SUBJECTS

Introduction to Machine Learning in Pharmaceutical Sciences (Theory)

Environmental Sciences (Theory)

Ethics and Universal Human Values (Theory)

General Pharmacology (Theory)

Heterocyclic Compounds and Stereochemistry (Theory)

Pharmaceutical Dosage Forms I (Theory)

Pharmaceutical Engineering (Theory)

Pharmaceutical Microbiology (Theory)

General Pharmacology (Practical)

Heterocyclic Compounds and Stereochemistry (Practical)

Pharmaceutical Dosage Forms I (Practical)

Nutraceuticals and Functional Foods

Food Analysis

Yoga and Life Sciences

4TH SEMESTER SUBJECTS

Herbal Drug Technology (Theory)

Medicinal Chemistry (Theory)

Pharmaceutical Biotechnology (Theory)

Social Pharmacy and Public Health (Theory)

Systemic Pharmacology I (Theory)

Herbal Drug Technology (Practical)

Medicinal Chemistry (Practical)

Pharmaceutical Biotechnology (Practical)

Social Pharmacy and Public Health (Practical)

Systemic Pharmacology I (Practical)

Internship (Mandatory)

5TH SEMESTER SUBJECTS

Biomedicinal Chemistry (Theory)

Industrial Pharmacognosy (Theory)

Innovation and Startup Ecosystem (Theory)

Pharmaceutical Dosage Form II (Theory)

Pharmaceutical Quality Assurance (Theory)

Systemic Pharmacology II (Theory)

Biomedicinal Chemistry (Practical)

Industrial Pharmacognosy (Practical)

Pharmaceutical Dosage Form II (Practical)

Systemic Pharmacology II (Practical)

6TH SEMESTER SUBJECTS

Advanced Pharmacognosy (Theory)

Biopharmaceutics and Pharmacokinetics (Theory)

Intellectual Property Rights (Theory)

AI Applications in Pharmaceutical Sciences (Theory)

Pharmaceutical Analysis (Theory)

Pharmaceutical Jurisprudence (Theory)

Green Chemistry

Materiovigilance and Hemovigilance

Admissions
Open 2026-27

Industry-oriented
learning

Modern campus
facilities

Academic excellence &
mentorship

Global opportunities &
placements